| Test performance evaluation of SARS-CoV-2 serological assays JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Nature biotechnology 38 (10), 1174, 2020 | 264 | 2020 |
| Evaluation of SARS-CoV-2 serology assays reveals a range of test performance JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Nature biotechnology 38 (10), 1174-1183, 2020 | 244 | 2020 |
| Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis JC Lee, S Mehdizadeh, J Smith, A Young, IA Mufazalov, CT Mowery, ... Science immunology 5 (52), eaba0759, 2020 | 168 | 2020 |
| Pooled knockin targeting for genome engineering of cellular immunotherapies TL Roth, PJ Li, F Blaeschke, JF Nies, R Apathy, C Mowery, R Yu, ... Cell 181 (3), 728-744. e21, 2020 | 163 | 2020 |
| Obesity alters pathology and treatment response in inflammatory disease SP Bapat, C Whitty, CT Mowery, Y Liang, A Yoo, Z Jiang, MC Peters, ... Nature 604 (7905), 337-342, 2022 | 109 | 2022 |
| The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes S Dong, KJ Hiam-Galvez, CT Mowery, KC Herold, SE Gitelman, ... JCI insight 6 (18), 2021 | 109 | 2021 |
| XYZeq: Spatially resolved single-cell RNA sequencing reveals expression heterogeneity in the tumor microenvironment Y Lee, D Bogdanoff, Y Wang, GC Hartoularos, JM Woo, CT Mowery, ... Science advances 7 (17), eabg4755, 2021 | 77 | 2021 |
| Trisomy of a Down syndrome critical region globally amplifies transcription via HMGN1 overexpression CT Mowery, JM Reyes, L Cabal-Hierro, KJ Higby, KL Karlin, JH Wang, ... Cell reports 25 (7), 1898-1911. e5, 2018 | 56 | 2018 |
| Chromatin accessibility promotes hematopoietic and leukemia stem cell activity L Cabal-Hierro, P van Galen, MA Prado, KJ Higby, K Togami, CT Mowery, ... Nature communications 11 (1), 1406, 2020 | 47 | 2020 |
| Rapid deployment of SARS-CoV-2 testing: The CLIAHUB ED Crawford, I Acosta, V Ahyong, EC Anderson, S Arevalo, D Asarnow, ... PLoS pathogens 16 (10), e1008966, 2020 | 22 | 2020 |
| Test performance evaluation of SARS-CoV-2 serological assays. MedRxiv. 2020 JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Publisher Full Text, 2020 | 18 | 2020 |
| Test Performance Evaluation of SARS-CoV-2 Serological Assays. medRxiv Prepr. Serv JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Health Sci 38, 1174, 2020 | 15 | 2020 |
| Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity S Weng, S Matsuura, CT Mowery, SA Stoner, K Lam, D Ran, AG Davis, ... Leukemia 31 (1), 159-169, 2017 | 15 | 2017 |
| Modular pooled discovery of synthetic knockin sequences to program durable cell therapies F Blaeschke, YY Chen, R Apathy, B Daniel, AY Chen, PA Chen, K Sandor, ... Cell 186 (19), 4216-4234. e33, 2023 | 8 | 2023 |
| Improved covid-19 serology test performance by integrating multiple lateral flow assays using machine learning CT Mowery, A Marson, YS Song, CJ Ye medRxiv, 2020.07. 15.20154773, 2020 | 6 | 2020 |
| Test performance evaluation of SARS-CoV-2 serological assays. 2020 JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Preprint https://doi. org/10.1101/2020.04 25, v1, 0 | 6 | |
| Test performance evaluation of SARS-CoV-2 serological assays. medRxiv. 2020: 2020.04. 25.20074856 JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto | 5 | |
| Test performance evaluation of SARS-CoV-2 serological assays. medRxiv 2020; published online May 17 JD Whitman, J Hiatt, CT Mowery | 4 | |
| Pooled knock-in screening and heterologous polypeptides co-expressed under the control of endogenous loci TL Roth, PJ Li, A Marson, J Nies, C Mowery, E Shifrut, F Blaeschke, ... US Patent App. 17/439,328, 2023 | | 2023 |
| Functional genomic and profiling approaches to characterize mammalian immunity C Mowery University of California, San Francisco, 2023 | | 2023 |
Andrew A. Lane, MD, PhDDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
